tm logo
POINT BIOPHARMA
Live/Pending
SUSPENSION LETTER - MAILED

mailed

on 11 Dec 2023

Last Applicant/ Owned by

22 St. Clair Ave East, Suite 1201

Toronto, Ontario

CA

M4T2S3

Serial Number

90093341 filed on 04th Aug 2020

Registration Number

N/A

Correspondent Address

John R. Rudolph

Eli Lilly and Company

Lilly Corporate Center

Indianapolis,IN 46285

Filing Basis

No Filing Basis

Disclaimer

"BIOPHARMA"

POINT BIOPHARMA

"BIOPHARMA" POINT BIO PHARMA Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Mark Details


Serial Number

No 90093341

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

Yes

44D Current

Yes

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.02 -

Plain single line circles

26.01.13 -

Two circles

Description of Design Search

The mark consists of the all-capitalized word "POINT" wherein the "P" and "O" are intersecting so the two interior circles are connected, and wherein the thinner, all-capitalized word "BIOPHARMA" sits directly underneath and to the right of the stem of the "P".

Legal History


Show more

Status DateAction Taken
12th Mar 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12th Mar 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12th Mar 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12th Mar 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Dec 2023SUSPENSION LETTER WRITTEN
11th Dec 2023LETTER OF SUSPENSION E-MAILED
11th Dec 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13th Jun 2023SUSPENSION LETTER WRITTEN
13th Jun 2023LETTER OF SUSPENSION E-MAILED
13th Jun 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED